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1. Introduction  
Stem cells have the potential to revolutionise medicine, providing treatment options for a 
wide range of diseases that currently lack a long term control strategy. In order for us to 
harness this potential, however, we need a thorough understanding of their self-renewal 
and differentiation capacities. Differentiation capacity, or ‘potency’, can be defined as the 
ability of a cell to give rise to every cell type within the developing embryo and its 
supporting tissues (totipotency), every tissue of the three germ layers: endoderm, ectoderm 
and mesoderm (pluripotency, Fig. 1.) or a restricted range of cell types (multipotency). The 
potency of a cell is dictated to some extent by the stage at which it is isolated from the 
embryo, which in turn affects its gene expression profile. For example, whereas embryonic 
stem (ES) cells are isolated from the inner cell mass (ICM) of the pre-implantation blastocyst, 
EpiS cells are derived from the later stage epiblast and exhibit significantly altered gene 
expression compared to mouse ES (mES) cells (Tesar et al., 2007). 
mES cells were first isolated from the ICM of the mouse blastocyst by two independent 
groups in 1981 (Evans and Kaufman, 1981; Martin, 1981) and have since been used as a 
model system in which to study mechanisms of development and disease. ES cells have also 
been isolated from other species including pig (Notarianni et al., 1990), rabbit (Graves and 
Moreadith, 1993) and chicken (Pain et al., 1996). In addition, pluripotent stem cells have been 
derived from cleavage-stage embryos, individual blastomeres (Chung et al., 2006; Klimanskaya 
et al., 2006; Wakayama et al., 2007), parthenogenic embryos (Lin et al., 2007; Mai et al., 2007; 
Revazova et al., 2007), trophectoderm (Tanaka et al., 1998) and extraembryonic endoderm 
(Kunath et al., 2005). Pioneering work in 1998 by Thomson and colleagues (Thomson et al.) 
resulted in the derivation of human embryonic stem (hES) cells from human blastocysts. 
Whilst mES and hES cells differ greatly in their gene expression profile (Tesar et al., 2007) 
and respond to distinct pluripotency-inducing signals (Daheron et al., 2004; Vallier et al., 
2005), the core pluripotency regulatory network of Oct4, Sox2 and Nanog is conserved 
between the two species. Numerous studies have demonstrated the formation of an Oct4/Sox2 
heterodimeric complex which is then responsible for activating the expression of a multitude 
of pluripotency-associated genes (Yuan et al., 1995; Botquin et al., 1998; Nishimoto et al., 
1999). Many of the Oct4/Sox2 gene targets have been shown to be shared with Nanog in 
both mES (Loh et al., 2006) and hES cells (Boyer et al., 2005). Insight into this core 
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Fig. 1. Pluripotent stem cells are defined as possessing the ability to form all cells of the three 
primary germ layers (endoderm, ectoderm and mesoderm). Multipotent stem cells can form 
some of the cells of the germ layers and, therefore, exhibit more restricted potency 
compared to pluripotent cells. 
regulatory network that governs the pluripotent state has recently led to the generation of 
induced pluripotent stem (iPS) cells from mouse (Takahashi and Yamanaka, 2006) and 
human somatic cells (Takahashi and Yamanaka, 2006; Yu et al., 2007; Hanna et al., 2008; 
Stadtfeld et al., 2008). These cells, obtained by overexpression of a cocktail of pluripotency-
associated genes (most commonly Oct4, Sox2, c-Myc and Klf4), have the potential to provide 
patient-specific cells for regenerative medicine strategies. The primary challenge of this 
research at present is the tumorigenicity of the transplanted cells, in one study 20% of mice 
injected with these cells developed tumors, likely to be due to the presence of the c-myc 
oncogene (Takahashi and Yamanaka, 2006). More recently, however, iPS cell generation 
from murine embryonic fibroblasts (MEFs) has been achieved without genetic alteration 
using recombinant proteins (Zhou et al., 2009). These cells, termed piPS (protein-induced 
pluripotent stem) cells, demonstrated both self-renewal and pluripotent capacities both in 
vitro (i.e. embryoid body formation) and in vivo (chimera generation). iPS cells have also 
been generated from patients suffering from a range of disorders including diabetes mellitus 
and Parkinson’s disease (Park et al., 2008), with such cells providing a useful system with 
which to study the progression of specific disorders. Whereas iPS cells are more likely to be 
suitable for therapeutic applications (largely due to the ease of matching HLA types of 
donors to patients), ES cell research continues to provide valuable data about the 
pluripotent state to inform iPS cell research. This knowledge will be key to the translation of 
iPS cell technology from the laboratory to a clinical setting. 
In recent years, evidence for the function of E-cadherin in regulating self-renewal signalling 
pathways, cell surface localisation of receptors and survival of ES and iPS cells has emerged. 
www.intechopen.com
The Function of E-cadherin in ES Cell Pluripotency   
 
127 
In this chapter, we discuss the function of E-cadherin in regulating pluripotent signalling 
pathways in ES cells, the importance of E-cadherin expression in hES cells and a 
mesenchymal-epithelial transition event that appears to dictate efficient derivation of iPS 
cells. In addition, we discuss epithelial-mesenchymal transition during human and mouse 
ES cell differentiation and highlight similarities between this process and tumour cell 
metastasis.  
2. Embryonic stem cell self-renewal 
2.1 mES cell self-renewal  
Mouse ES cells were originally isolated and maintained in an undifferentiated state by co-
culture with mitotically inactivated MEFs. More recently, however, advances have been 
made to more clearly define the specific combinations of signals that activate key 
pluripotency pathways. The interleukin-6 family cytokine leukaemia inhibitory factor (LIF) 
has been shown to be crucial for mES cell self-renewal in vitro. Upon LIF engagement, gp130 
forms a heterodimeric complex with the LIF receptor ┚ subunit allowing its activation and 
the subsequent stimulation of three parallel signalling cascades; phosphatidylinositol-3-OH 
kinase (PI3K)/Akt, Janus kinase (Jak)/signal transducer and activator of transcription 3 
(STAT3) and Grb2/mitogen activated protein kinase (MAPK). PI3K/Akt and Jak/STAT3 
pathways converge to activate the core pluripotency mediators Sox2 and Nanog whilst the 
Grb/MAPK pathway inhibits Tbx3-mediated stimulation of Nanog and Sox2 (Niwa et al., 
2009) (Fig. 2.).  
 
      
Fig. 2. The LIFR/gp130 signalling pathway stimulates expression of Sox2 and Nanog in 
mouse ES cells via various intermediate components. Adapted from Niwa et al, 2009 (Niwa 
et al., 2009).   
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Whilst LIF has been shown to prevent mesodermal and endodermal differentiation, the 
transforming growth factor ┚ (Tgf ┚) family member bone morphogenic protein 4 (Bmp4) is 
also required to block neuroectoderm lineage specification within mES cell cultures. Bmp4 
has been shown to perform this function by activating transcription of the inhibitor of 
differentiation (Id) genes via Smads1/5/8 (Ying et al., 2003). Together, LIF and BMP4 are the 
major components of a media formulation known as Clonal Grade Medium (Millipore, 
Watford, UK) which can maintain mES cell pluripotency in the absence of animal serum.  
mES cells can also be maintained in an undifferentiated state in the absence of LIF and Bmp4 
in medim supplemented with antagonists of MAPK and glycogen synthase 3 (Ying et al., 
2008). Additional pathways that have been linked to self-renewal include the PI3K/Akt 
signalling cascade, likely due to its key role in LIF signal propagation, and the canonical 
Wnt pathway. Canonical Wnt pathway activation has been shown to support self-renewal in 
both mES and hES cells (Sato et al., 2004) and, more recently, to derive FAB stem cells, so-
called due to the factors used in their isolation (Fibroblast growth factor 2 (Fgf2), Activin 
and BIO, the latter a Wnt pathway activator) (Chou et al., 2008).   
2.2 hES cell self-renewal 
Unlike mES cells, hES cell pluripotency is not reliant upon the LIF signalling network 
(Daheron et al., 2004). Instead, hES cell self-renewal has been shown to be supported by the 
Tgf┚ family ligands Activin and Nodal, in combination with Fgf2 (Vallier et al., 2005) (Fig. 
3.). When bound to their Activin-like kinase (Alk) receptors, Activin, Nodal and Tgf┚ initiate 
a signalling cascade involving the phosphorylation of Smads2/3. These transcription factors  
 
 
Fig. 3. Pathways associated with pluripotency and self-renewal in hES, mouse E-cadherin-/- 
ES cells and EpiSCs.  
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then form a complex with Smad4 allowing them to translocate to the nucleus and activate 
target genes (Massague and Chen, 2000), including Nanog (Vallier et al., 2009). Interestingly, 
mouse EpiS cells have been shown to require the same molecular milieu as hES cells and 
human iPS cells to maintain pluripotency (Brons et al., 2007) and their global gene 
expression pattern also more closely resembles the hES cell transcriptome than that of mES 
cells (Tesar et al., 2007). 
3. E-cadherin 
Both mES and hES cells grow as tight colonies and their integrity is maintained by cell-cell 
contacts, such as adherens junctions (AJ), of which a major component is E-cadherin (Fig. 4.). 
E-cadherin is a well-characterised member of the calcium-dependent cadherin superfamily. 
E-cadherin is a glycoprotein and is categorised as a type 1 classical cadherin due to its 
possession of a histidine-alanine-valine (HAV) sequence in the extracellular domain. The 
role of cell-cell adhesion remains fundamental throughout embryogenesis and E-cadherin 
plays a critical role in the sorting of mixed cell populations to allow tissue segregation 
(Cavallaro and Christofori, 2004). This key developmental role is evidenced by studies in E-
cadherin null (-/-) mutant embryos, which fail to form a trophectodermal epithelium or 
compact and form a blastocyst cavity due to the loss of cell-cell contact (Larue et al., 1994). 
The role of E-cadherin in cell-cell adhesion is facilitated by its five extracellular (EC) 
domains and a cytoplasmic region, the latter of which allows stabilisation of the molecule 
at the cell membrane via its interaction with p120ctn, ┚-catenin and ┙-E-catenin  
 
 
Fig. 4. Diagrammatic representation of adherens junctions formed by E-cadherin 
interactions. E-cadherin cis-homodimers interact with identical homodimers on 
neighbouring cells (homophilic interaction) with cell-cell adhesion most often associated 
with identical cells (homotypic adhesion). For simplicity, only E-cadherin is represented in 
the AJ. 
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Fig. 5. Diagrammatic representation of E-cadherin cis-homodimers and the cytoplasmic cell 
adhesion complex. EC – extracellular domain; MPED – membrane proximal extracellular 
domain. 
(possibly via Epithelial Protein Lost In Neoplasm). Together these molecules make up the 
Cytoplasmic Cell adhesion Complex (CCC) which anchors E-cadherin to the actin 
cytoskeleton (Fig. 5.). There is some controversy surrounding the roles of specific regions of  
E-cadherin in cell-cell adhesion, however, there is evidence for a critical role of the HAV 
domain, located on residues 79-81 of EC1, in cell-cell contact. The HAV domain is thought to 
form a hydrophobic pocket into which a Tryptophan residue (Trp2) from an adjacent E-
cadherin molecule docks (Cavallaro and Christofori, 2004). Mutations of Trp2 and the 
Alanine residue of the HAV domain, W2A and A80I respectively, were shown to abolish 
trans- but not cis-homodimerisation of E-cadherin molecules, thus demonstrating the key 
roles of these amino acids in the formation of E-cadherin-mediated cell-cell contact (Pertz et 
al., 1999). Additional roles for EC4 and the membrane proximal extracellular domain 
(MPED) of E-cadherin in homophilic adhesion have been evidenced by the E-cadherin 
targeting antibody DECMA-1, which abolishes cell-cell contact by interacting with these 
regions (Ozawa et al., 1990). 
3.1 Function of E-cadherin in ES cells 
3.1.1 E-cadherin regulates localisation of cell surface molecules 
Loss of E-cadherin in ES cells imparts significant alterations within the cellular architecture 
and can result in mis-localisation of cell surface proteins. For example, we have 
demonstrated that loss of E-cadherin in mouse and hES cells results in translocation of the 
promigratory molecule 5T4 from the cytoplasm to the plasma membrane and that this is 
associated with altered actin cytoskeleton arrangement and induction of cell polarisation 
(Eastham et al., 2007; Spencer et al., 2007). In addition, it has been reported that E-cadherin 
mediated cell-cell contact regulates expression of Eph receptors and Ephrins (Orsulic and 
www.intechopen.com
The Function of E-cadherin in ES Cell Pluripotency   
 
131 
Kemler, 2000). Therefore, E-cadherin appears to play a critical role in regulating cellular 
architecture and, thus, localisation of plasma membrane proteins. This is supported by our 
unpublished observations which suggest that E-cadherin also functions to maintain plasma 
membrane localisation of a range of proteoglycans in ES cells (Soncin et al, unpublished 
data). As a result, E-cadherin should not be seen as simply a cell adhesion protein but an 
important molecule for maintaining the integrity of epithelium and ES cell colonies. 
Surprisingly, little has been reported on the function of altered E-cadherin expression in cell 
surface protein localisation. Since loss of E-cadherin is a defining event in tumour cell 
metastasis it is possible that cell surface proteins regulated by E-cadherin expression could 
provide novel targets for tumour therapies. 
3.1.2 E-cadherin expression regulates signalling pathways in pluripotent cells 
We have recently shown that E-cadherin-/- mouse ES cells do not respond to LIF when 
cultured in medium supplemented with foetal bovine serum (FBS). Although E-cadherin-/- 
ES cells exhibit an undifferentiated phenotype in medium supplemented with FBS/LIF, the 
cells maintain pluripotency and self-renewal by utilising Activin, Nodal and Fgf2 present 
within ES-screened FBS (Soncin et al., 2009) (Fig. 3.). E-cadherin-/- ES cells can be cultured 
in an undifferentiated state in serum-free medium supplemented with Activin A, Nodal and 
Fgf2 and exposure of the cells to the Activin-like kinase receptors (Alks)-4, -5 and -7 
inhibitor (SB431542) under these conditions induces their differentiation (Soncin et al., 2009). 
Mutant E-cadherin protein analysis in our lab demonstrated that the ┚-catenin binding 
domain of E-cadherin is critical for LIF/Bmp-mediated pluripotency in ES cells. Although E-
cadherin-/- ES cells utilise Activin/Nodal signalling as a default pluripotent pathway in 
serum-supplemented medium they are also able to maintain pluripotency via LIF/BMP 
signals in the absence of Activin/Nodal (Soncin et al., 2009). Therefore, E-cadherin-/- ES 
cells possess a functional “ground state” pluripotent signalling network (Ying et al., 2008) as 
well as the ability to circumvent this pathway by utilising Activin and Nodal. Our results 
suggested that mES cells exhibit a hierarchy of pluripotency signalling pathways and this 
was confirmed by our observation that reversible Activin/Nodal-dependent pluripotency 
could be induced in wild type (wt)ES cells by their treatment with an E-cadherin 
homodimerisation-inhibiting peptide (CHAVC). Interestingly, ┚-catenin null (-/-) ES cells 
are also able to maintain an undifferentiated state in the absence of LIF and, similar to that 
observed in E-cadherin-/- ES cells, this is achieved via Activin, Nodal and Fgf2 signalling. 
Therefore, the CCC appears to play a major function in regulating LIF-dependent 
pluripotency and self-renewal of mES cells.  
We have performed global gene array analysis of E-cadherin-/- mES cells and detected 
>2000 transcript alterations compared to the wild-type parental cell line (Soncin et al, 
unpublished). Surprisingly, the altered transcripts detected in the array of E-cadherin-/- ES 
cells were not only confined to cell adhesion and motility but also genes associated with a 
range of biological functions, such as primary metabolic processes, catabolism, apoptosis 
and differentiation (Soncin et al, unpublished data). E-cadherin-/- ES cells also exhibited a 
transcriptional phenotype more similar to epiblast-derived cells, suggesting that loss of E-
cadherin expression may determine the ICM-to-epiblast transition. Therefore, E-cadherin 
does not function solely as an adhesion molecule in mES cells but also to regulate 
transcription associated with a diverse range of cell functions, maintain appropriate growth 
factor responsiveness of the cells and retain plasma membrane localisation of a range of 
molecules.  
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3.1.3 Culture of mES cells in shake flask suspension culture using an E-cadherin 
neutralising antibody 
Adherent methods for the culture of ES cells are cumbersome, result in significant batch-to-
batch variation and are costly and labour-intensive. Given the requirement in regenerative 
medicine to reproducibly derive sufficient numbers of cells of a consistent quality in a cost-
effective manner we have been investigating the use of bioreactors for the suspension 
culture of ES cells. The advantage of such an approach over existing adherent methods is the 
ability to design a scaleable, non-intensive and relatively homogeneous high cell volume 
density microenvironment that can be monitored in silico. E-cadherin has been 
demonstrated to be the cause of aggregation of ES cells in suspension culture (Fok and 
Zandstra, 2005) and several groups have suggested that abrogation of E-cadherin in ES cells 
results in low cell viability (Fok and Zandstra, 2005) and could adversely affect the 
pluripotent status of the cells when cultured in bioreactors (Dang et al., 2004). However, our 
data in E-cadherin-/- ES cells demonstrated that these cells could be cultured in static 
suspension culture and maintain pluripotent marker expression over 30d (Mohamet et al., 
2010). Furthermore, we have recently demonstrated that wild type mES cells can be cultured 
as a near single cell suspension over prolonged periods in scalable shake flasks in the 
absence of additional media supplements (Mohamet et al., 2010). Using the E-cadherin 
neutralising antibody DECMA-1 we have shown that wtES cells exhibit doubling times of 
15.6h±4.7 and mean-fold increase in viable cell numbers over 48h of 16±0.9. Under these 
conditions, wtES cells could be cultured for 15d whilst maintaining expression of 
pluripotency markers and high cell viability. In addition, the cells exhibited a normal 
karyotype and, subsequently, were able to differentiate to cells representative of the three 
primary germ layers (Mohamet et al., 2010). Culture of ES cells in shake flasks provides a 
useful cost-effective method which significantly decreases the requirement for technical 
input and plastic consumables associated with current adherent methods.  
3.1.4 E-cadherin expression enhances hES cell colony formation and self-renewal 
Several studies have identified the Rho-associated kinase (ROCK) inhibitor Y-27632 as a 
potent factor for increasing the survival of dissociated hES cells (Watanabe et al., 2007). 
Recently, it has emerged that Y-27632 is likely to function by stabilising E-cadherin protein 
at the plasma membrane, allowing re-aggregation of the dissociated cells ( Li et al., 2009). 
Stabilisation of E-cadherin at the cell surface of disaggregated hES cells was associated with 
expression of the apoptotic inhibitory gene Bcl-XL and inhibition of the pro-apoptotic gene 
Caspase-3 (Li et al., 2009). Forced expression of E-cadherin in dissociated hES cells increased 
clonogenicity up to 20-fold and cells lacking E-cadherin were shown to undergo cell death 
or differentiation within 48h. Similarly, Xu and colleagues (Xu et al, 2009) identified a small 
molecule, Thiazovivin (Tzv), which was observed to promote cell aggregation in suspension 
by inhibiting endocytosis of E-cadherin. The authors identified ROCK as a direct target of 
Tzv and concluded that inhibition of the ROCK pathway reflected the increased survival of 
hES cells treated with Tzv. It has also been shown that functional interactions between small 
GTPase Rap1 and E-cadherin is responsible for regulating self-renewal of hES cells (Li et al, 
2009.). Colony formation and self-renewal of hES cells was found to be suppressed by 
inhibition of Rap1 as a consequence of altered endocytic recycling of E-cadherin. We have 
observed that culture of hES cells with the E-cadherin neutralising antibody SHE78.7 results 
in decreased proliferation of the cells (Eastham et al., 2007), perhaps reflecting degradation 
of Rap1 in these cells (Li et al, 2009). Therefore, stabilisation of E-cadherin at the plasma 
membrane appears to be critical for the survival of disaggregated hES cells. 
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Several studies have utilised plates coated with E-cadherin-Fc protein to demonstrate 
increased survival of hES cells (Nagaoka et al, 2010 ; Xu et al, 2009). Culture of hES or iPS 
cells on E-cadherin-Fc coated plates exhibited a normal karyotype and maintained 
pluripotent marker expression over 60 days (Nagaoka et al, 2010). These cells were 
subsequently induced to form cells representative of the three primary germ layers by their 
culture as embryoid bodies or following formation of teratomas. The plating efficiency of 
disaggregated hES cells was found to be decreased by proteolytic degradation of cell surface 
E-cadherin which could be prevented by the use of non-proteolytic dissociation buffer. As a 
result, E-cadherin-Fc coated plates may represent a useful method to provide a defined 
substratum for the growth of human ES and iPS cells. 
3.1.5 E-cadherin expression enhances iPS cell derivation 
Derivation of iPS cells represents a useful alterative to the use of human embryos for 
isolation of pluripotent cells as well as allowing the investigation of genetic mutations 
during cell lineage formation. Recently it has been suggested that nuclear reprogramming of 
mouse fibroblasts to iPS cells requires a mesenchymal-epithelial event (MET) (Li et al, 2010.).  
When MET was blocked during iPS cell-induction the derivation of such cells was found to 
be significantly reduced. In addition, low chimaera forming ability of iPS cells was 
associated with low levels of E-cadherin protein expression. However, recent evidence has 
suggested that low chimaera-forming ability of cells is associated with inefficient 
incorporation of the cells into the ICM, rather than a true lack of pluripotency of the cells (Li 
et al., 2010; Chou et al., 2008). 
Improved iPS cell derivation has been demonstrated by Chen and colleagues (Chen et al., 
2010) who isolated two small molecules that enhanced E-cadherin expression. To confirm 
the function of E-cadherin in the iPS-derivation procedure they forced expression of E-
cadherin in MEFs and showed that this increased iPS-derivation rates 4-fold. Inhibition of E-
cadherin expression using RNAi or an inhibitory peptide during iPS cell derivation lead to 
decreased iPS cell isolation. Interestingly, in contrast to signalling pathway alterations 
described by Soncin et al (Soncin et al., 2009), the ┚-catenin binding domain of E-cadherin 
was not required for efficient iPS cell derivation and instead was dependent on the 
extracellular domain of the protein. We have previously demonstrated that the ┚-catenin 
domain of E-cadherin is required to restore cell-cell contact in E-cadherin-/- ES cells (Soncin 
et al., 2009), suggesting that the function of E-cadherin in iPS cell derivation reflects a 
requirement for cell-extracellular matrix (ECM) interaction rather than cell-cell adhesion. 
Therefore, E-cadherin appears to function via two discreet mechanisms; firstly, as a 
regulator of pluripotent signalling pathways via the CCC and, secondly, as an enhancer of 
ES cell-ECM interactions to aid cell survival. 
4. Loss of E-cadherin during ES cell differentiation 
4.1 Epithelial-mesenchymal transition  
Epithelial-mesenchymal transition (EMT) events involve the conversion of a cell from an 
epithelial to a more motile mesenchymal phenotype. This process is associated with a switch 
from E-cadherin expression to a less adhesive cadherin, such as N-cadherin. Coordinated 
EMT events are important during embryogenesis, for example, to allow the ingression of 
epiblast cells within the primitive streak during gastrulation. However, aberrant EMT-like 
events have also been implicated in tumorigenesis whereby a cell is transformed to a more 
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metastatic phenotype, leading to tumor cell invasion of the surrounding tissues. Therefore, 
E-cadherin is considered to be a metastasis suppressor gene (Vleminckx et al., 1991). The role 
of E-cadherin down-regulation during tumorigenesis is likely to be two-fold; loss of E-
cadherin-mediated cell-cell contact initiates morphological changes as well as affecting the 
signal transduction status of the cell (Mohamet et al., 2011). EMT has been shown to be 
stimulated by various signalling cascades and loss of E-cadherin has been shown to affect 
signalling via a variety of receptor tyrosine kinases, such as, the epidermal growth factor 
receptor and the hepatocyte growth factor receptor c-Met (reviewed in Cavallaro and 
Christofori, 2004). The upregulation of N-cadherin that occurs during EMT events can also 
affect signalling pathways such as those mediated by Fgf receptor 1 and may contribute to 
the increased cell survival and invasiveness that is characteristic of cells that have 
undergone an EMT event (Suyama et al., 2002; Cavallaro and Christofori, 2004). 
4.1.1 EMT during ES cell differentiation 
As well as their potential use in regenerative therapies ES cells are an excellent model 
system for elucidating mechanisms involved in development and disease. We have 
demonstrated that an EMT event occurs during mouse (Spencer et al., 2007) and human 
(Eastham et al., 2007) ES cell differentiation and that this exhibits striking similarity to 
processes associated with ingression of epiblast cells within the primitive streak and tumour 
cell metastasis. The ES cell EMT event is associated with an E- to N-cadherin switch (Fig. 6.), 
upregulation of Snail, Slug and Sip1 (E-cadherin transcript repressors) and increased 
gelatinase activity and cellular motility (Fig. 7.). Whilst cell density can affect the extent to 
which the E- to N-cadherin switch occurs in adherent ES cell culture, EMT is often observed 
during embryoid body culture (Ward, unpublished). 
The exact reason for the EMT event during ES cell differentiation remains unclear, although 
it is likely to reflect early events associated with embryogenesis. Furthermore, EMT during 
ES cell differentiation appears to be a regulated event, unlike the process associated with 
tumour cell metastasis. We have shown that loss of E-cadherin during ES cell EMT  is 
associated with lack of pluripotent transcripts in E-cadherin-negative cells (Spencer et al., 
2007). As a result, E-cadherin expression can be used as a useful non-invasive tool to assess 
the pluripotent status of ES cells (Spencer et al., 2011). Since EMT/metastasis is difficult to 
study in vivo, ES cells may provide a useful model system for the study of this process 
(Eastham et al., 2007; Spencer et al., 2007). 
Our analysis of the EMT event during mES cell differentiation has enabled an 
understanding of the hierarchy of this process. For example, whilst induced loss of E-
cadherin expression in ES cells resulted in increased cellular motility it did not result in an 
EMT-like event, with transcripts for Snail, Slug, Sip1 and MMP2/9 remaining unchanged 
(Spencer et al., 2007). This suggests that loss of E-cadherin is not responsible for induction of 
EMT in ES cells. We also assessed EMT during differentiation of N-cadherin-/- mES cells 
and showed that these cells exhibited a characteristic EMT event similar to that of the 
parental cell line. Therefore, localisation of N-cadherin at the plasma membrane, and 
possible subsequent activation of signalling cascades during this process, are unlikely to be 
critical for the onset of EMT in mES cells, although N-cadherin-/- ES cells did exhibit 
significantly decreased motility compared to wtES cells. Therefore, whilst loss of E-cadherin 
and gain of N-cadherin are associated with an EMT event during ES cell differentiation 
these proteins do not appear to initiate nor control this process.  
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Fig. 6. An EMT event occurs during mES cell differentiation. (a) Mouse ES cell spontaneous 
differentiation is associated with loss of cell surface E-cadherin (E-cad) protein and gain of 
cell surface N-cadherin (N-cad) protein. (b) Fluorescent flow cytometry dual staining for E- 
and N-cadherin on ES cells differentiated for 3d. (c) Western blot analysis of total cellular E- 
(E-cad) or N-cadherin (N-cad) proteins in ES cells differentiated for 3, 6, 9 and 12 d. (d) RT-
PCR analysis of E- (E-cad) and N-cadherin (N-cad) and ┚-tubulin (┚-tub; control) transcript 
expression during ES cell differentiation. Images in these figures have been previously 
published in full or in part by ASCB 
(http://www.molbiolcell.org/cgi/content/full/18/8/2838#F1) 
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Fig. 7. Mouse ES cell differentiation is associated with expression of the E-cadherin 
repressors Snail and Slug, matrix metalloproteinase activity, and increased motility. (a) 
Transcript expression of Snail, Slug, E12/E47, and ┚-tubulin (┚-tub; control) in 
undifferentiated ES cells (day 0) and in cells differentiated for 3, 6, 9, and 12 d. (b) Transcript 
expression of MMP-2 and -9, tissue inhibitor of metalloproteinase (TIMP)-1 and -2 and ┚-
tubulin (┚-tub; control) in undifferentiated and differentiating ES cells. (c) Cellular motility 
of undifferentiated and differentiating (3 d in the absence of LIF) wild-type ES cells was 
assessed using Costar Transwell 5-µm pore size plates. Data represents the fold change in 
motility compared with undifferentiated cells. Images in these figures have been previously 
published in full or in part by ASCB 
(http://www.molbiolcell.org/cgi/content/full/18/8/2838#F1) 
5. Conclusion 
E-cadherin is emerging as a key regulator of human and mouse ES cell pluripotency and 
self-renewal and is challenging long-held views of signalling pathways in these cells. For 
example, we have demonstrated that mES cells possess at least two functional pluripotent 
pathways that are dependent upon E-cadherin protein expression levels (Soncin et al., 2009). 
Whilst the exact mechanisms controlling the switch between LIF/BMP and Activin/Nodal 
pathways in mES cells are not fully understood it is clear that E-cadherin functions to 
maintain the hierarchy of these independent pathways. We have also observed that 
abrogation of E-cadherin in hES cells can alter dependence of the cells to FGF2 signalling 
(Ward, unpublished), suggesting that E-cadherin also functions to regulate pluripotency 
pathways in human cells.  
Current evidence suggests that E-cadherin plays several roles in ES cells. Firstly, E-cadherin 
functions to maintain cell-cell contact and this is likely to effect localisation of plasma 
membrane proteins. Our demonstration that E-cadherin inhibits cell surface localisation of 
the pro-migratory factor 5T4 (Eastham et al., 2007; Spencer et al., 2007) suggests that E-
cadherin expression exerts a physical effect on the localisation of plasma membrane 
proteins. Unpublished data in our lab has revealed that loss of E-cadherin in mES cells does 
not affect cell surface expression of gp130 or the LIFR (Hawkins, unpublished), suggesting 
that alterations in signalling pathways in E-cadherin-/- mES cells are not due to changes in 
the localisation of pluripotency-associated receptors. The exact reason for the switch from 
LIF/BMP to Activin/Nodal dependent pluripotency in mES cells lacking E-cadherin is not 
clear. Indeed, we have found that inhibition of E-cadherin-mediated cell-cell contact using 
b a c 
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the neutralising antibody DECMA-1 does not stimulate Activin/Nodal-dependent 
pluripotency in mES cells. Therefore, the exact region(s) of E-cadherin which regulate 
LIF/BMP-dependent pluripotency in mES cells remain unknown. The third function of E-
cadherin appears to be in regulating the expression of several thousand transcripts in mES 
cells. Whilst many of these mRNA changes are likely to reflect indirect transcriptional 
regulation by E-cadherin, it serves to highlight the importance of this protein in maintaining 
cellular homeostasis. The fourth function of E-cadherin in ES cells appears to be specific to 
human pluripotent cells: Enhancement of cell survival in dissociated cell populations. mES 
cells do not exhibit significant cell death when dissociated into single cells, indeed, this is 
desirable for maintenance of an undifferentiated population, and E-cadherin-/- ES cells 
exhibit almost 2-fold increased proliferation compared to wt mES cells (Soncin et al., 2009). 
The effect of loss of E-cadherin in disaggregated hES cells appears to reflect endocytic 
cycling of the protein leading to decreased stability at the cell surface. However, hES cells 
are able to proliferate, albeit more slowly, upon inhibition of E-cadherin and maintain 
expression of pluripotent markers (Eastham et al., 2007). The key difference between loss of 
E-cadherin expression in hES and mES cells, therefore, appears to be cellular disaggregation 
in the absence of a substratum. For example, whilst hES cells maintain viability in adherent 
culture following treatment with the E-cadherin neutralising antibody SHE78.7, the majority 
of the population die within 24h when cultured in suspension (Mohamet et al., 2010). In 
summary, E-cadherin exhibits a range of functions in ES cells which result in stabilisation of 
epithelial integrity and associated signalling pathways. As a result, E-cadherin should no 
longer be classed as a mere cell adhesion protein but as a fundamental regulator of ES cell 
homeostasis and identity. 
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